申请人:Solvay Pharmaceuticals GmbH
公开号:US05952327A1
公开(公告)日:1999-09-14
Compounds having NEP-inhibitory activity, corresponding to the formula I in which R.sup.1 is hydrogen or a group forming a biolabile phosphonic acid ester, R.sup.2 is hydrogen or a group forming a biolabile phosphonic acid ester and R.sup.3 is hydrogen or a group forming a biolabile carboxylic acid ester and physiologically acceptable salts of acids of formula I, and pharmaceutical compositions comprising these compounds.
具有NEP抑制活性的化合物,对应于公式I,其中R.sup.1是氢或形成生物可陌生磷酸酯的基团,R.sup.2是氢或形成生物可陌生磷酸酯的基团,R.sup.3是氢或形成生物可陌生羧酸酯的基团,以及公式I的酸的生理上可接受的盐,以及含有这些化合物的药物组合物。